drugset / Trial / NCT02984696

Total Antioxidant Capacity Before and After HRT in Hypotalamic Amenorrhea

NCT02984696

NaSingle-groupOpen-labelTreatment

Summary

The aim of our study is to investigate the effects of 6 months oh HRT on total anti-oxidant capacity, clinical, endocrine and metabolic features in women affected by hypotalamic amenorrhea. The study group included 20 patients treated with 1 mg of transdermal estradiol daily and 10mg of oral Medroxyprogesterone acetate from 16th to 24th day of therapy for six months. Menstrual pattern, anthropometric parameters, hormonal assays, DXA and bone metabolism parameters are evaluated before and after therapy.

Timeline

Start
2015-03
Primary completion
2016-10
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 1 mg Other
Subject medroxyprogesterone acetate Other / unclassified 10 mg Oral